How to cite item

Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain

   
@article{ATM26131,
	author = {Jose M. Pacheco and Dexiang Gao and D. Ross Camidge},
	title = {Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 ≥50%, but unanswered questions remain},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {Suppl 3},
	year = {2019},
	keywords = {},
	abstract = {Platinum-based doublets were the recommended systemic therapy for newly diagnosed patients with stage IV non-small cell lung cancer (NSCLC) for decades. Median overall survival (OS) for patients whose first treatment was these chemotherapy regimens was 8–12 months and 5-year OS was estimated at 2% (1-3).},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/26131}
}